T1	Participants 16 89	seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias.
T2	Participants 434 476	patients with ventricular tachyarrhythmias
T3	Participants 581 589	Patients
T4	Participants 1035 1059	486 randomized subjects.
T5	Participants 1307 1319	296 patients
